New formulation helps RNA vaccines withstand high temperatures

MIT researchers used an AI algorithm to develop a new lipid nanoparticle formulation that makes RNA vaccines stable at room temperature for up to a year and at 100°F for two months. This advancement could ease vaccine distribution and enable new delivery methods like microneedle patches. Tests in mice showed the vaccines elicited immune responses comparable to existing mRNA Covid-19 vaccines.